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A pplication o f all-tl'nlls retinoic acid to human skin 
for 4 d under occlusion produces a marked increase in 
retin oic acid 4-hydroxylase activity. In this s tudy, the 
possible induction of other hydroxylases in response 
to 9-cis and 13-cis retinoic acid applications to adult 
h u m a n skin ;1/ ";"0 was dete rmined. Application of 
0. 1'% all-tl'n1/s , O. l '!lo 9-cis, and 0.1% 13-cis retinoic acid 
to h uman skin for 2 d resulted in induction of only 
all- tl'nl/S r etinoic acid 4-hydroxylase activity. The 4-hy-
droxylase activity in microso!Des from the treated tissue 
ranged from 383 ± 46 to 531 ± 59 pg of 4-hydroxy 
all-tl'nl/S r etinoic acid formed/min/mg prote in (n = 6). 
T h ese same prepar ations were unable to u se 9-cis or 
13-cis r etinoic acid as substrate for the hydroxylation 
r eaction. Extraction of the retinoic acid isomers frOiTI 
epidermis 48 h after application of 0.1 % solut ion of each 
hen hum an [1] o r rat skin [2] is treated 
topically with ail-traIlS re tino ic ac id (I-IU), a 
m arked ind uction of IU 4-hydroxylase oc-
curs. Becau se this hydroxylase m ay limi t the 
activity o f I-IU, 9-cis IU, and 13-cis lU, 
we in vestigated the time course fo r inductio n of JU h yd roxylase, 
the specific ity of the enzym e w ith the three isomers of RA, re tino l 
(R.OL), and retinaldehyde (lU L) as substrates, and possibl e induc-
tion of other hydroxylases in respo nse to the topi ca l app lication of 
9-cis lU or 13-cis RA. 
M ATERJ A LS AND M ETH ODS 
Isocitrate . isocitrate dehydrogenase. N AD P. 13-cis RA. I-RA, 'I3-cis 
RAL, 9-ds RA L, 1-ltA L. '13-(;, R OL, and I- R OL were purchased fro m 
Sig ma C hemica l Co. (St. Lo ui s, MO) . T ri tiated I-IV\. and ' H-I- R O L were 
obta ined from D uPont NEN (Boston . M A) . 'I-cis ItA, 9-cis ROL, ' H-9-cis 
ItA. ' H-'13-ris IV\ were g ifts fro m D rs. J oseph G rippo. Arthu r Lev in . P . F. 
Sorter , and A.A. Liebma n of Hoff';llann La R oche Co . (N u tley. NJ ). R A 
Ill em bo li tes , 4-0 1-1 I-RA, 4-0"0 I- Lv\, 4-0,,0- 13-cis ItA. and 5,6-epoxy 
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95% ethano l: prop),lc ne g lyco l (7:3. vol/vol) w ith 0 .5 mg bu r),lated 
hyd roxytoluene / ,nl . 
isomer yielded significant amounts of all-tl'alls retinoic 
acid (36-72%) regardless of the isomer applied. The 
all-tI'n1!s isomer produced by isomeriza tion of both 9-cis 
and 13-cis retinoic acids is the likely inducer of the 
4-hydroxylase. All-tl'nl/s retinol and all-tl'nl/S retinal were 
unable to compete with all-tl'nllS retinoic acid as sub-
strate for 4~hydroxylase enzyme. The 4-hydroxylase 
induced in respol;lse to pharmacologic~ doses of reci-
noic acids is specific for the all-tl'nllS isomer. The inabil-
ity of 9-cis or 13-cis retinoic acid to induce their own 
hydroxylation and inactivation or act as substrate for 
the 4-hydroxylase in skin may have considerable impli-
cations in light of the clinical use of retinoids in the 
treatment of various diseases including ·cancers. Key 
words: metabolisml[somel,;z atiolllplwl'IIwcoio'!''J,lcytocill'ome P450. 
] [,West D el'llwtoi106:316-320, 1996 
ItA , w ere g ifts fro m D rs. Michael R osenbe rger and P. F. Sorte r of H o f1ill anll 
La R oche . AII-Imlls IV\ O. I 'Yo (R etin-A) an d cream vehicl e we re supplied br 
O rtho Pharmaceutica l Corp . (Ra r it:lIl. NJ ). High- perfo rm ance li q ui d chro-
m atography (H PLC) grade so lve n ts were used for extractio n and chro mato-
g raphic solven ts. Sphe ri sorb ODS- I colu m ns w ere o b ta ined fi'o m Phose 
Separa tio ns (Norwal k . CT). 
Application of Compounds and Biopsy Procedure Solu tions of 
I~OL (1. 6'1.,). I-ItA (0 .1%), 13-cis ItA (0. 1%) and 9-cis I~A (0 .1%) wcre 
prepared in a ve hicl e consisting of 95% ethanol and propylene g lyco l (7:3. 
vol/vo l) containing 0.5 m g b u tylated hydroxyto luene/ml of solu tion (EPG). 
T he use of EGP as vehicle was required since o nl y I-ItA was ava il able in 
c ream base used in the ini ti al studi es 11"1 . These so lutio ns and ve hi cle wcre 
appli ed to pica ll y to a 3 X 2-inch area o n th e bu t tocks. T he area is occluded 
and kept dark fo r ind icated pe ri ods o f t ime. usuall y 2 o r 4 d. T he 4-d time 
po in t gave consisten t ctini ca l cva lqatio ns and 'was the t ilHe se lected in the 
in itial studies . T he 2- d time point, ho wever, is adequate fo r biochemical 
stu'dies w ithout cl in ica l corre latio ns. ·I~he trc:lted a reas were in fi ltrated with 
1 % lidoca ine loca l anesthes ia and keratol1l cd ep idermal t iss uc (O.l - ml11 
dep th) was immediatel y frozen in liquid ni trogen an d stored at - 70°C until 
used . All subjects gave in formed . w ri tte n consen t. The study waS approved 
by the U nivers ity of Michiga n M edica l Center Insti tuti o nal R eview Board. 
Extraction of Retinoids Oiopsy sites were tape sClipped to g listening 
prior to b iopsy to re m ove an y rctino id t rap ped in dead stratulll corncum that 
was not absorbed into the viable laye rs of th e sk in . Procedures were as 
p' revio usly stated [11 . B ri eRy, frozen kerato m e biops ies were g round to a 
powder under liquid nitrogen w ith a m o rtar and pestl c. T he matc.rial was 
quickly transfe rred to a ho m ogenizer con t:l ining th e extractio n so lvents 
(c hlorofo rm and m ethano l [2 : I D wi th t r:lcer -' I-l-I-RA (to es timate recov-
e ri es) all d w as ho m ogenized. After two add it io nal ex tractions. the organic 
phase was eva po rated, resuspended . fi ltered . an d injected o nto the HPLC 
colullln . Protein deterlllinatio ns were by the m eth od of Lowl)' el ,, / [3] with 
bovine senllll .. lbull1ill as a standard. 
0022-202X/96/S I 0.50 • Copyrigh t 1996 by T he Society fo r In vestigative Derm atology. Inc. 
316 
VOL. 106. N O. 2 FEBRUARY 1996 
700 
c: 
c: ~ 600 
.2 Q: 
~ a; 500 
~ E 
& g 400 
c( 2 
~ ~ 300 
OD> 
-t -E 200 
:I: .5 
M E 
~ 100 
0-'--'------'--------
16 Hrs 16 Hrs 24 Hrs 48 Hrs 96 Hrs 
Figure 1. Time course for induction of RA-4 hydroxylase activity 
after topical application of 0 .1 % t-RA cream to adult human skin 
under occlusion. ' H-i-I"lA (2 J.LM) and an NADpH regenerating system 
"vas incubated ;11 /l ill 'a with I"ni crosorncs fro nl ti ss lI es treated ill vi/lo with I-ItA 
cre am. Other assay conditions and separation of metabo lites arc given in 
Materials ami Met/lOris. D , vch icle; • . s,"nples fi'ol11 f-l"lA sites treated for the 
tUnes indicated . Thl! num ber of individual subjects from whom microsomes 
were prepared at the indicated time po ints arc as fo llows: n = 6 for vchicle 
and f-1"lA treated for 16 alld 24 h: 11 = 8 lor 48 h; n = 5 fo r 96 h. Ermr bars. 
SEM, for each seri es. 
EnzyITle Assays Microsomal fractions were prepared as previously de-
scribed [1]. RA and RA metabolites were kept in amber glass in darkenl!d 
rooms with yellow lighting. The rate of R A metaboli sm was determined by 
incubating 100 J.Lg microsomal p rotein in 0.01 M phosphate buifer, pH 7.4 , 
containing an NADPH regenerating system and 3H-f-I"lA or other tritiated 
rerinoids as substrates. Samples were incubatl!d for 30 Illin at 35°C. T he 
ac tivity is expressed as picograms of 4-0H R A fo rmed pCI' minute pe r 
mjlligram of microsomal prote in . Compounds tested as possible competiti ve 
substrates were added to the assa)' mi" just prior to t:h e addition o f .lH-I-I"lA. 
T he reaction was terminated by addition of l OO fl,\ of Illethanol cooled to 
- 20°C . 
HPLC Separation An l-lI'LC sYStl!1ll (1090M ; Hewlett-Packard Co .. 
Pa.lo Alto , CAl containing a Sphl!l'iso rb OOS-1 co lulllll (25 X 4.6 11'11'11 ). a 
d iode arra y de tector and a chenl workstation was lI sed to sepa rate and 
quantitate retinoids and metabolites 1 ]. T hl! sta lldard compounds used to 
ca librate the co lumn contained the fo llowing retino ids: 4-0 H H..A; 4-oxo-
13-cis 1"lA; 4-oxo t-I"lA ; 5,6 epoxy I"lA; 13-cis RA; 9-";.< 1"lA; f-I"lA; 13-( i" 
ROL; f-I"lO L; 'I3-cis RAL; f-I"lAL. A gradient e lution sYStl! 11l separatl!d the 
retinoids and mctabolites in a 42-m il1 time peri od . EfHu cnt li'om the HpLC 
column Rowed directly into a Row through scintillation counter (Flo-Onl! 
Beta model 295A , Packard Instrument Co., Meriden , CT) with a comput-
erized data capture system to determine radioactivity in each peak. T hl! 
amount of metabolite fort11l!d was calculated based on the spec ific activ ity of 
added [' H.lre tinoid. 
RESULTS 
Time Course of RA 4-Hydroxylase Induction in Micro-
s omes Isolated from Human Skin Following III Villo Appli-
cation of 0 . 1°;', t-RA A m:u-ked inductio n ofr-l~ 4-h ydrox ylase 
was reported after human skin had b een exp osed to 0. 1 'X, f -I~ 
continuollsly for 4 d unde r occlusive patch [1]. Figure 1 shows that 
in compadson to c ream base o nly (45 ::t 15 pg/ min / m g microsomal 
prote in) , no RA 4-hydroxylase induction occurre d at 16 h aft e r 
applica tion of f-I~ in c re am base (5 6 ::t 1 8 pg/ min / m g pro te in). In 
data no t shown, there is no signifi cant d ifference in 4-h ydroxy lase 
activity in c rea m base only treated areas in comparison to areas 
receiving n o treatment. T h e base line 1~ 4-h ydroxylase activity 
varies with diffe rent individu als fi:om b arely d e tectable to m o d e rate 
activity. Twenty-four h o urs after a sin g le application of r-RA in 
cream base, a 10-fold induction of [~ 4-h ydroxylase activ ity (569 
± 14 2 pg/ min / m g protein) had occurred. Similar activities we re 
m aintaine d 48 o r 96 h afte r app lication of f-l~ , as shown ill Fig 1. 
T h e time lag of great!'r than 1 6 h but less than 24 h for th e ill c rease 
in I~ 4-h ydroxylase activ ity includes the time re quired to r pene-
tration of th e r-l~ , activation of gene t ranscrip t ion, and mR.NA 
and prote in synthesis. 
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Figure 2. 9-cis RA and 13-cis RA isomers of I-ItA. are not su bstrates 
for RA 4-hydroxylase activity induced by topical application of 
0.1% t-RA cream. Assay condi tions arc given in "'gend to Fig 1 cxce.pt (or 
th e addition o f the un labeled isomers. T he number of microsomal fractions 
used arc as fo llows: vehide (n '" 3). and ' H-f-I"lA (n = 13); for added 9-ris 
1"lA-2.S J.LM (n = 7). 10 J.LM, (n '" 3), and l Oa J.LM (n = 6); fo r added 
13-d" R.A-'IO J.LM (n = J) and 60 ,...M (n = 6). Error lim: ... SEM. Using 
Student's r rest for paired samples, there was no sign.ifi cant difFerence in 
.I-O H 1"lA fo rmation in till! presence or nbsenel! of 1"lA isomers (p > 0.5). 
9-cis RA and 13-cis RA as Substrates for RA-4-Hydroxylase 
in Skin To tes t wh eth e r o r n ot the all - rratts confi g uratio n was 
n ecessary for I~ to b e a substrate for the indu ced enzym e , 
n o nradioactive 9-cis and i3-cis R A were adde d as compe titive 
substra tes for the " H-f-RA ill th e sta ndard it, lI;fro assay . The data 
a re given in Fig 2 . T h e 3 H - f-RA con centra tion was 2 {LM with 
4-0H f-RA formatioll of 3 15 ± 46 pg/min / m g protein . T h e 
addition of n o nradioac tive 2.5 {LM 9-cis [~, 10 /-LM 9- cis RA. or 
100 /-LM 9-( is l~ did not sig llifi cantly dec rease the am o unt of 
"H-4-0H I-RA fo rme d (ave rage of3 17 pg/min/mg protein for a ll 
9-cis l~ con centrati o ll s). Figure 2 also sh ows tha t similar results 
were obtain ed if n onradioa ctive 10 /-LM 13-cis I~ o r 60 /-LM 13-r;s 
l~ w e re present in the assay (average of 323 pg/ min / m g protein 
for both con centratio n s of 13-cis l~). T hus, n e ith e r 9-cis l~ nor 
1J-cis RA were abl e to compe te with r-RA as substra te fo r th e 
e n zym e reaction . 
In con trast, Fig 3 shows that the addi tion of unlab e le d f-ItA to 
2 /-LM 3H-r-RA d ecreased the DPM present in th e 4- 0H r-l~ and 
this decI'case was propo rti onal to the d ecrease in specific ac tivity of 
the 3H-r-RA . B ased o n the specifi c activ ity of th e subsu'a te, th e re 
is n o ch an ge in en zymatic activity (751 ± 1 22 pg/min / m g protein 
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F igure 3 . Addition of unlabeled t-RA decreases the formation of 
' H-4-0H I-RA but not the quantity of 4-0H I-RA. Assays were as 
given in legend to Fig 1 except ndditiona1 unlaheled f- l"lA was added. 
Fo rmation of 4-0H f-RA (pg) was ca lculated based on specifi c activity of 
added substrate. Microsomes were prepared from human skin treated ill I'il''' 
with 0 .1% t-RA crealn (n = 3). Err"I' bars. SEM. 
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F igure 4. QU3_ntitics of 9-cis RA, 13- cis RA, a nd I-RA extracted 
from human skin following ill ''; (J/J application in EPG of 0.1% of 
each isomer for 48 h at different sites on the same individuals. JI) 
Nallogn1l11s per gram wct weight of each RA isomer and I-ROL extracted 
from the skin. T he stratum corneum was stripped prior to keratoming. 
Extracted materia l from treated areas: vehicle (0 ); C)-cis RA (!I'JlI); 13-cis RA 
~; with I- ItA (.); ROL (bJ). Em". bars , SEM (n = 7). B) T he percentage 
of each isomer was calculated based on the sum of nanograms of extracted 
rt.As from each site as '100%,. O ne gram of tissue = 1 1111 was used to 
calculate nanomoiars, 
at 4 fLM RA, 785 ± 112 pg/min/mg protein for 12 fLM RA, and 
800 ± 96 pg/min/mg protein for 24 fLM RA) . 
Extraction of RA Isomers Present in Epidermis 48 h After 
ill Vivo Application of Vehicle, 9-cis RA, 13-cis RA and l-RA 
to Human Skin All th ree RA isomers are soluble in EPG at a 
concentration of 0. 1 'Yr •. Two days after application of vehjcl e (EPG) 
and th e three RA isom ers in EPG to four different sites under 
occl usio n on the buttock, the stratum corneulll (o uter layers of th e 
ski n) was rem oved by tape stripping. T hi s was n ecessa ry ill o rde r to 
avoid erroneously high va lues for RA content in the viable layers 
due to unabsorbed material remaining on the surface of the skjn. 
Retinoic ac ids were extracted from the stripped, keratomed 
tissue and the amount of each RA isomer determined. T hese data 
arc presen ted in Fig 4A,B. The bar g raph in F ig 4A displays the 
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3H-9-cisRA 3H-13-cis RA 
In Vitro Substrates 
Figure 5. All-Imlls RA 4-0Hase activity induced in hnman skill 48 
h after ;11 V;II0 application of C)-cis RA, 13-cis RA, or I-RA. Unlabeled 
RA isomers were applied ill IIivo ill EPG solution for 48 h. Al l three tritiated 
isomers were used as substrates ill the ill vilro assay. Assay procedures given 
in legend to Fig 1 and in Maler;als at,,1 Met/lilels, Errol' I)(/rs. SEM, ror seVCIl 
different microsomal preparations: vehicle (0 ); with 9-cis RA (!I'JlI); with 
B-cis RA (fS3); with I- I~ (.). 
nanograms per gram wet weigh t of each RA isomer extracted from 
each of the treated areas. T he sum of the nanograms for the three 
RA isome rs fo r each treated site is defi ned as 'I OO'X •. T he indi vidual 
isome rs extracted from a given site are expressed as a p ercentage of 
the sum and displayed in pie chart fo rm in F ig 4B. Molar 
concen tratio n of each RA isomer is also g iven for the fo ur treated 
sites in Fig 4B, T h e tota l n anogram s of the three isomers of RA 
extracted fi'om th e epidermis at each treated site were similar 
(145-188 ng RAs/g wet weigh t of tissue). A ll - Iralls RA (solid bar) 
was the most stable isom er with 72% of the applied isomer 
remaining as I-RA and achieved a con cen tration within epidermis 
of 0.45 fLM. A significant po rtion of tota l retinoic acids extracted 
from the tissue was I-RA regardless of the isom er appljed (36% in 
9-cis RA application areas, 55% in l3 -cis RA appli cation areas, and 
72%, in l-RA application areas). 9-cis RA (II (lITO II! ', atched b(JJ's) was 
recovered fi'om 9-cis lZA- treated areas (52%) and from I-RA-
treated areas (1 %), but no ne was detected in the 'I3-cis r~-treated 
areas. 13-cis R A (wide hatelm/ btlrs) was recovered frol11 aJl of the 
treated areas . 
Induction of 4-Hydroxylase Activity in Epidermis 48 h After 
ill Vi JJIl Application of Vehicle, 9-cis RA, 13-cis RA, and I-RA 
to Human Skin In a second sel'ies, th e same solutions of the 
three RA isom ers were applied and kept occluded fo r 2 d. Since RA 
isom ers remainin g on th e surf.Ke would not in terfere with ejther 
the mic"osomal preparation or the ill ,) il l"O assay, th e stratU1l1 
corne um was not removed by tape strippin g prior to the keratome 
procedure. The results of th e ill IJitro assays for ]ZA 4-hydroxylase 
activity are depicted ill Fig 5. With 3H_l_RA as su bstrate, 4-0H 
I-RA was fo rmed b y microsomal fractions fro m areas treated with 
each of the three isomers. T he activity associated with 9-cis 1~ 
treated areas was 53 1 ± 59 pg/min/mg protein , with 13-cis R A 349 
± 68 pg/min / l11 g protein and with I-RA 448 ± 68 pg/ l11in /mg 
prote in (n = 7). The ve hicle va lu e was 70 ± '16 pg/l11in/mg protein 
(n = 7). With 3H - 9-c is RA or 3H-13-cis ItA as substrate , no 
hydroA),lated prod ucts were formed sin ce n o new peaks of radio-
activ ity were detected in the reg ion w here more po lar compounds 
c lu te (i.e., compounds with reten tion times ea rlier th an 13-cis RA 
[28 min]) . 
Application of t-ROL Increases RA 4-Hydroxylase Activity 
A solution of 1.6')/0 t-ROL in EPG was app li ed to ad ul t human skin 
for 4 d under occl usion . Microsomal fractions were prepared from 
these treated areas an d were in cubated ill " jIm with 3H-I-ROL or 
3H_l_RA as substrate . As shown in Fig 6. the application of I-ROL 
or I-ItA induced the l-RA 4-hydroxylase activity based on the ill 
IJ itro assay with 3H_I_RA as substrate. A ll - im lls RA was a m uch 
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Figure 6 . AlI - I,·"" s RA 4-0Hase activity induced in human skin 96 
h after application of 1.6'Yo, I-ROL or 0.1% t-RA. Tritiated t-RA o r 
r- ROL were substrates in the assay of microsomes o btained from areas 
treated ;11 ,,;"" with r- RA or t- R OL in EPG so lution. ErJ'C)r b(/ rs, SEM (Il = 5, 
for 3H-I-ROL as substrate; Il = -I , for ' I-I-I- I~ as substrate). 0 , vchicle; • . 
O.l'Yo I-RA; ~ , 1.6% t-ROL. 
more e/licient inducer ofRA 4-bydroxylase (841 ::!: 58 pg/ min/ m g 
microsomal protein, n = 4) in comparison to (-ROL (391 ::!: 32 
pg/min/mg protein , n = 5). T he rate of hydro xylation of t-RA in 
microsom es £i'om vehi cle-treated areas was 28 ::!: 17 pg/min/ mg 
protein (n = 4). When microsomal fra ctio ns prepared from the 
ROL-treated areas were assayed fo r ROL hydroxylase activity, 
there was no formation of 3 H - 4-OH R OL since no radi oactive 
peaks were detected at retention times consistent with po lar 
metabolite formation even at a substrate concentration of 20 f-LM 
3H-I-ROL. Altbough 4-01-1 ROL ca n be oxidized to additiona l 
metabolites in other tissues, no unidentified peaks were presen t in 
the chromatogram s from these incubations. 
Other retinoids tested for their capacity to function as alternative 
substrate were the other two ROL isomers and the three co rre-
sponding RAL isomers. These retinoids (20 f-LM) were added to the 
standard ill r/ilro assay containing 3 H-I-R..A , which resulted in a 
7-fold excess of R..OLs or RALs compared with 31-1-I-RA. T he 
microsom es used in the irr pilro assays were obtained from areas 
t~eated with OJ'!!., I-ItA. As shown in Fig 7 , there was a 10-fold 
inductio n of 4-hydroxylase activity 765 ::!: 67 pg/min/ m g micro-
so mal protein (11 = 18) for the I-RA trea ted areas compared with 63 
::!: 14 pg/ min / mg protein (n = 18) fo r vehicle-treated areas. T here 
w ere no significant decreases in the amoLlnt o f "H-4-0 H I~RA 
formed b y the addition to the assay of any retin ol o r retinal iso mer. 
T he activity in the presence of20 f.LM I-ROL o r t- R..AL was 700 ::!: 
101 pg 4-0H I-RA/ min / mg protein (11 = 6) or 958 ::!: 148 
pg/min/mg protein (11 = 6). T hese values are not signifi cantly 
different from I-RA alone. 
DISC USSI ON 
The clinical usc of retinoids t-ItA and 13-ci5 R.A in topica l 
preparations circumvents one o f the cell 's control poin ts (the rate of 
synthesis of R..As) for maintaining the necessary concentration of 
I-RA. M etabo lism of th e added retinoids to less active metaboli tes 
is one of the m echanism s that can be used to litnit effects of topically 
applied retinoids. Whil e little is known about the specifi cs of 
retinoid metabolism and inactivation in skin, the indu ction of a 
4-hydroxylase activity in response to topica l application of I-ItA is 
known [1,2]. A major m etabolite of t:\-cis RA found in blood 
fo llowing o ral administration is 4- oxo-1 3-ci5 R A [4], a stable 
4-hydroxylated metabolite of 1.3 - ':;5 ItA. III lIit l'cl incuba tio n of 13-cis 
RA with a 9,OOOg supernatan t fraction frOI11 rat li ver prod uced the 
same metabolite [5]. H ydroxylation ma ybe the main m echanism for 
inactivation of RA s. T he possibility e xisted that the cytochro me 
P450 4-hydroxylase indu ced in response to I-RA in skin migh t also 
hydroxylate the other isomers (i .e ., 9-cis RA and 13-cis R A) in skin. 
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Vehicle 3H-RA t ROl 9c ROL 13c ROl t RAl 9c RAL 13c RAL 
Figure 7 . Three isomers ofROL and RAL do not compete w ith the 
transforlnation of ' H-l-RA to 4-0H RA ;11 " itf'{) witIt microsomes 
obtained fro m areas exposed to 0_1% t-RA creanl ;11 ";"0 for 96 h _ 
Assays COITlpOn c nts as given in legen d ro Fi g 1. Un lab e le d 9-cis, 13-cis. :l l1 d 
all-rrnlls isomers of retinol (20 J.LM) and retinal (20 J.LM) were added to the 
i/l " itf'() assay in a 7-fo ld excess of the substrate ' H-l-RA. Ermr brtf:\,. SEM (n 
= 18, for assays with vehicle o r ' H-t-RA alo ne; n = 6 for all other 
cxpcril11 cnts given). 
T he data demonstrate that th e 4-hydroxy lase induced fo llowing 
application of I-RA is specifi c for r-RA. Since retinoids arc known 
to isom erize with exp osure to air and li gh t, the stability of each 
isom er during pene tration in to the viab le layers of the skin was 
determined. T he resul ts show that i-RA was th e m ost stable of the 
three isomers and that rega rdless of the isom er of RA applied , at 
least 40 - 50':;') of the IlA in the viable layers of the epidermis is 
isom et'ized to I-RA . T hese data are consisten t w ith recen t data 
obtained with ra t li ver micl'Osomes itt II ilro [6] . In the report, 
40-50°/., of the added 13-cis RA was converted into I-RA after a 
30-min incubation at 37°C whereas o nly 11 '% of 'ldded I-RA was 
isom erized into 13-ris RA . 
T he isom erization of the appEed 9-cis RA and 13-cis R..A to I-RA 
in the skin would explain the observed indu ction o f the I-RA 
4-hydroxylase in the epidermis regardl ess of the isom er appl.i ed . A 
sufficient level of I-RA was formed by isom eri zation of 9-cis and 
13-tis IlA so tha t the sam e results w ere produced as if i-RA had 
been applied (i.e ., induction of I-RA 4-hydro,,:ylase). It is also 
important to note that ne itller 9-cis RA nor 13-cis RA "vere able to 
induce a hydro"'y lase activity in skin that wou ld resu lt in inactiva-
tion of these isom ers. 
Liver, however, docs appear ab le to metabolize I 3-cis IlA by 
hydroxy lation. Ex perim ents with mice showed that feeding 13-ris 
R..A increased elimination of 13-cis RA only in liver, w hereas 
feeding t- R..A increased the eliminatio n of r-ItA in al l tissues studied 
[7] . In other studies microsomal preparatio ns fi'om mouse liver but 
not m o use skin we re able to hydroxyla te 13-ci5 RA in an itt "i fro 
assay system (8] . 
III human li ver cytochro me P450 2C8 hydroxylates not on ly 
t-RA but also I-ROL 19 ] and rabbit liver 1'450 2B4 and 1 A2 
hydroA'Ylate bo th I-ROL and t-RAL (10]. Both of these studi es 
were can;ed o ut w it.h purifi ed cytochrome P450s . Sin ce topica l 
appli ca tion of ROL to adu lt hurmlll skin prod uces m any of the 
sam e efFects as RA [1"\], we determined w hether f-IlOL could 
indu ce a f-ROL and / or I-RA 4-h ydroxylase. Since convers io n of 
ROL to l~ m ay be neceSS<l t'Y fo r induction o f RA 4-h ydroxylase 
activi ty, a mu ch higher concen tration of ROL was used to assure 
adequate penet.ration and conversion to l:z.A. Topical application of 
1 .6% flOL, a concentra tio n 16- fo ld > I-RA, did indu ce R A 
4-hydroxylase acti vity, but to a lesser extent, 46. 5% of that 
achieved with 0 .'.1 % I-itA. In contrast to the P450s in liver. 
however, the skin P450 induced by f-ROL did not hydroxylate 
i-ROL as indicated by a lack of conversion of ' H-ROL to m ore 
po lar compo un ds in the ill I'itro assay system. Whi le 4-0H ROL is 
less stable than 4-0H RA. the fo rmation of 4-0H ROL w ith skin 
as the e nzym e source should ha ve been detected if formed since ill 
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11 ;11'0 assay system was simi lar to that used to detect 4-0H ROL w ith 
li ve r as the enzym e so urce 19, 10] . 
T he skin appears to tightl y control its I-l~ levels by stri ct 
limitation of its formation fi·om R OL and by specifi c inac tivation 
through 4-hydroxylation. Ski n does not appear, however, to have 
a direct means of controlling 13-ci5 or 9-r ;s RA levels after topica l 
applica tion , other dUlI1 isom erization to I-RA o r possibly glucu-
ronidation . 
In activation of app lied 13-r;s RA co uld be absorpti o n into the 
blood stream and transport to the liver fo r conversio n to 4- 0 H -
13-cis RA by on ly cytochro me P4502C8 fowld ill li ve r 19 ]. Such an 
inactiv ation, however, if it occurs in liver, would not be clinically 
important because topica l application of I-RA and j 3-cis RA in m an 
produ ces slight and va.·iab le changes in blood levels o f these 
retin oids [12 ,13]. T here fore, loca l inactivation in the skin of 
topicall y applied , natura lly occurring stereoisomers of RA via a 
fi nal common isomerization pathway to I-I~ and subsequ ent 
4-hydroxylation appears to be a cri t ical detoxificatio n mechan ism 
in skin . At the present time li ttl e is known abo ut the whjch P450 
associated enzyme ca rries out th is reactio n in skin. T he use of 
su bstrates and inhibito r specifi c for a 1'450 enzyme fa mily has not 
shed lig ht on th is qu estion (unp ubl ished data). Lik ewise, the 
presence of CRABP I or II in the assay did not alte l· the rate of RA 
4-hydroxylation (unpublished results). 
Las tl y, the kin ds of expe riments described in this article arc 
difficul t to perform in noncutaneous tissues . N oneth eless, sho uld 
other tissues be similar to skin in the ir capacity to convert 9- and 
13-cis RA to I-RA for in activation , the mechanisms described here 
may ha ve considerable impljcations fo r the treatment of system ic 
diseases such as ae rodigesti ve tract cancer and aClI te promyelo cytic 
leukemi a with the natural isomers o f RA [14,:1 5] . 
T"e nllt""rs I"nllk R"MII Gnrdeller for "er eXl'erlise ill nl'l'l)'illg Ih e «lI l1pOllllds, 
rell/ ell/ill,!! ofstrnllllll rom elllll lI'ith tnpc s t ril'pill.~ wh clI rcqllired, IIml kernloll/illg (U'the 
trented IIrells . We nrc nlso illdebfed t" Jlldith Srfllllifl for her tecllllicni eXl'ert ise nml 
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